Mis à jour
XXII - Falling wedge reversal
Market settling down and XXII poised for recovery at 0.236 Fib entry of $3.25.
Not good if it goes below this.
Wait for CCI to turn upward -150 range, likely within next day trading.
Look for resistance to break upward in next week for next area most likely 0.5 (2.50).
Solid stock for nicotine free tobacco and acquisition candidate.
Cannabis stocks started upward this week as safe have and Cboe IX hitting 16. Currently at safer 13.45.
Links:
tradingview.com/symbols/AMEX-XXII/
finstead.com/posts/XXII-buy-or-sell/
Q2 2018 Earnings report: finance.yahoo.com/news/22nd-century-2q-earnings-snapshot-233240120.html?.tsrc=rss
Not good if it goes below this.
Wait for CCI to turn upward -150 range, likely within next day trading.
Look for resistance to break upward in next week for next area most likely 0.5 (2.50).
Solid stock for nicotine free tobacco and acquisition candidate.
Cannabis stocks started upward this week as safe have and Cboe IX hitting 16. Currently at safer 13.45.
Links:
tradingview.com/symbols/AMEX-XXII/
finstead.com/posts/XXII-buy-or-sell/
Q2 2018 Earnings report: finance.yahoo.com/news/22nd-century-2q-earnings-snapshot-233240120.html?.tsrc=rss
Transaction en cours
Keyboard Kowboy makes good point of bouncing off this line for those who need to capture and reentry. At some point this is resistance broken for LONG. BTI, MO, PM acquisition as approvals for XXII in China coming. 
Trade fermée: cible de profit atteinte
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.